Drugs.com Newsletter Archive

Our popular newsletter containing a regular roundup of medication news, alerts and new drug approvals.

Archive

Recently Approved

Symtuza Symtuza (darunavir, cobicistat, emtricitabine and tenofovir alafenamide) is a once daily,...
TPOXX TPOXX (tecovirimat) is an orthopoxvirus-specific antiviral indicated for the treatment of human...
Qbrexza Qbrexza (glycopyrronium) is a topical anticholinergic contained in a single-use, pre-moistened,...
Braftovi Braftovi (encorafenib) is a kinase inhibitor indicated, in combination with binimetinib, for the...

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions & Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated June 1st, 2018), Cerner Multum™ (updated July 4th, 2018), Wolters Kluwer™ (updated June 4th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.

Drugs.com Newsletter Archive

Archive

Support

About

Terms & Privacy

Drugs.com Newsletter Archive

Archive

Drugs.com Mobile Apps

Support

About

Terms & Privacy